CHILDREN'S DIMETAPP LONG-ACTING COUGH PLUS COLD OTC
Generic Name and Formulations:
Chlorpheniramine maleate 1mg, dextromethorphan HBr 7.5mg; per 5mL; syrup; grape-flavor; alcohol-free; contains sodium 3mg/5mL.
Pfizer Consumer Healthcare
Indications for CHILDREN'S DIMETAPP LONG-ACTING COUGH PLUS COLD:
Rhinorrhea, allergy symptoms, cough.
20mL every 6 hours; max 4 doses/24 hours.
<6yrs: do not use. 6–11yrs: 10mL every 6 hours; max 4 doses/24 hours.
Children <6yrs old. During or within 14 days of MAOIs. For use as a sedative hypnotic.
GI or GU obstruction. Glaucoma. Asthma. Lower respiratory disorders. Pregnancy. Nursing mothers.
Antihistamine + antitussive.
See Contraindications. Hypertensive crisis with MAOIs. Avoid alcohol. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, excitability in children.
Syrup—4oz (w. dosing cup)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age